Zeiss reveals Humphrey Field Analyzer II-i with Guided Progression Analysis software

Article

Carl Zeiss Meditec has unveiled the most advanced visual field testing platform available today - the Humphrey Field Analyzer II-i (HFA II-i) with Guided Progression Analysis (GPA) software.

Carl Zeiss Meditec has unveiled the most advanced visual field testing platform available today - the Humphrey Field Analyzer II-i (HFA II-i) with Guided Progression Analysis (GPA) software. The new system has been designed to accurately determine the stage of glaucoma and progression rate.

The GPA programme, which uses Visual Field Index, has been developed based on data from a 15 centre international clinical trial. It allows the platform to automatically summarize a patient's visual field test results, rate of visual field deterioration and therefore risk of future vision loss, which is then printed onto a single page in a simple format.

According to its manufacturers, HFA II-i with the new GPA software helps doctors to ensure that their glaucoma patients receive the best course of treatment and that vision loss is prevented or minimized.

Carl Zeiss Meditec also announced a host of new product and software upgrade launches at this year's ASCRS congress in Chicago, US. Their product portfolio now includes advanced algorithms for the Cirrus HD-OCT and Stratus OCT systems, new OCT software for their Visante OCT platform and an integrated workflow system for ophthalmic surgery (CALLISTO eye).

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.